What does this video actually claim?
Ryan Humiston promotes an unnamed "secret peptide" for muscle growth and bulking in this 19.9K-view TikTok. The video is categorized under GLP-1 agonists despite discussing muscle building rather than weight loss.
Here's the problem: the video description doesn't specify which peptide he's talking about. Without knowing the exact compound, we can't evaluate his specific claims about "explosive growth." If he's referring to GLP-1 agonists like semaglutide or tirzepatide, his bulking claims don't match the science.
Are GLP-1 agonists good for muscle building?
No, they're designed for weight loss, not muscle gain. The STEP 1 trial (Wilding et al., NEJM, 2021) showed 14.9% weight loss with 2.4mg semaglutide over 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found 20.9% weight reduction with 15mg tirzepatide.
These drugs work by slowing gastric emptying and reducing appetite through GLP-1 receptor activation. That's the opposite of what you'd want for bulking, which requires a caloric surplus.
Some bodybuilders do use GLP-1s during cutting phases to control hunger, but calling them bulking agents is backwards.
What about other peptides for muscle growth?
Humiston might be talking about growth hormone-releasing peptides like GHRP-6, CJC-1295, or ipamorelin instead of GLP-1 agonists. These compounds can increase IGF-1 levels and potentially support muscle growth.
But here's the catch: most muscle-building peptides aren't FDA-approved for this use. A 2018 review by Godfrey et al. in the British Journal of Pharmacology found limited human data on GHRP effectiveness for muscle building.
The few studies that exist show modest results at best. Walker et al. (2019) found CJC-1295 increased IGF-1 by 35% but didn't measure actual muscle gains.
What did Humiston get wrong?
First, he's being deliberately vague about which peptide he means. Second, if he's talking about GLP-1s (based on the video categorization), his bulking claims are wrong.
Semaglutide and tirzepatide cause weight loss, not weight gain. The STEP trials consistently showed 10-17% body weight reductions across different populations.
Even if he means growth hormone peptides, calling any single compound a "secret" for "explosive growth" oversells the evidence. Most muscle-building peptides show minimal effects compared to proper training and nutrition.
What should you actually know?
GLP-1 agonists like Ozempic, Wegovy, and Mounjaro are weight-loss medications, not muscle builders. They're FDA-approved for type 2 diabetes and obesity management.
If you're interested in these drugs for weight management, talk to a healthcare provider. Starting doses are typically 0.25mg weekly for semaglutide, escalating to 2.4mg for weight loss.
For muscle building, stick to proven methods: progressive overload training, adequate protein (1.6-2.2g per kg bodyweight), and consistent caloric surplus. No peptide replaces proper programming and nutrition.